missing translation for 'onlineSavingsMsg'
Learn More

FCRN/FCGRT Antibody (CL3640) [PE], Novus Biologicals™

Mouse Monoclonal Antibody

Marke:  Novus Biologicals NBP2-61627PE

Artikelnummer. 30305676

  • 737.00 € / 0.10 Milliliter

Bitte Sie sich an, um diesen Artikel zu kaufen. Sie benötigen ein Web-Konto? Registrieren Sie sich noch heute!

Dieser Artikel kann nicht zurückgegeben werden. Rückgaberichtlinie anzeigen

Beschreibung

Beschreibung

FCRN/FCGRT Monoclonal antibody specifically detects FCRN/FCGRT in Human samples. It is validated for Immunohistochemistry,Western Blot,Immunohistochemistry (Paraffin)
TRUSTED_SUSTAINABILITY
Spezifikation

Spezifikation

FCRN/FCGRT
Monoclonal
PE
alpha-chain, Fc fragment of IgG, receptor, transporter, alpha, FcRn, FcRn alpha chain, FCRNimmunoglobulin receptor, intestinal, heavy chain, IgG Fc fragment receptor transporter alpha chain, IgG receptor FcRn large subunit p51, major histocompatibility complex class I-like Fc receptor, Neonatal Fc receptor, neonatal Fc-receptor for Ig
This antibody was developed using a recombinant protein derived from P55899, with the exact immunogen sequence remaining proprietary.
0.1 mL
Immunology
2217
Store at 4⪚C in the dark.
IgG1
Immunohistochemistry, Western Blot, Immunohistochemistry (Paraffin)
CL3640
PBS
Mouse
Protein A purified
RUO
Primary
Human
Purified
Produktvorschläge

Produktvorschläge

Videos
Sicherheitsdatenblatt (SDS)
Dokumentation

Dokumentation

Zertifikate
Aktionen

Aktionen

Berichtigung von Produktinhalten

Bitte geben Sie uns Ihr Feedback zu den Produktinhalten, indem Sie das folgende Formular ausfüllen.

Name des Produkts

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.